BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10730341)

  • 1. [Immunologic risk analysis of blood transfusion: 1991-1998].
    Rouger P; Le Pennec PY; Noizat-Pirenne F
    Transfus Clin Biol; 2000 Feb; 7(1):9-14. PubMed ID: 10730341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of transfusion to the wrong patient in Germany.
    Caspari G; Alpen U; Greinacher A
    Transfusion; 2002 Sep; 42(9):1238-9. PubMed ID: 12430685
    [No Abstract]   [Full Text] [Related]  

  • 3. [Final bedside verification: results of a national survey of reagents and devices used in France].
    Noizat-Pirenne F; Le Pennec PY; Lascaux JM; Fraval D; Zaoui F; Rouger P
    Transfus Clin Biol; 1998 Dec; 5(6):392-6. PubMed ID: 9894330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ABO discrepancies occurring in 35 French hospitals.
    Chiaroni J; Legrand D; Dettori I; Ferrera V
    Transfusion; 2004 Jun; 44(6):860-4. PubMed ID: 15157252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood transfusion and monitoring. Immediate transfusion reactions. Erythrocyte transfusion].
    Riche H
    Soins; 1996 Apr; (605):23-6. PubMed ID: 8716245
    [No Abstract]   [Full Text] [Related]  

  • 6. [Yes, we should keep ABO agglutination test within bedside transfusion checks].
    Daurat G
    Transfus Clin Biol; 2008 Nov; 15(5):322-6. PubMed ID: 18930425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consecutive national surveys of ABO-incompatible blood transfusion in Japan.
    Fujii Y; Shibata Y; Miyata S; Inaba S; Asai T; Hoshi Y; Takamatsu J; Takahashi K; Ohto H; Juji T; Sagawa K
    Vox Sang; 2009 Oct; 97(3):240-6. PubMed ID: 19476605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immuno-hemolytic transfusion reactions. III. Report of 61 cases].
    Le Pennec PY; Tissier AM; Mannessier L; Agulles O; Babinet J; Bidet ML; Bombail-Girard D; Cabaud JJ; Cartron J; Chiaroni J; Desaint C; Krause C; Lamy B; Meyer F; Mortelecque R; Nafissi S; Rasongles P; Schweitzer B; Rouger P
    Transfus Clin Biol; 1996; 3(3):157-65. PubMed ID: 8925110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accidental transfusion with ABO-incompatible blood: process for analysis of the contributing causes].
    Indrikovs AJ
    Sangre (Barc); 1997 Jun; 42(3):205-13. PubMed ID: 9381263
    [No Abstract]   [Full Text] [Related]  

  • 10. [The pretransfusion bedside agglutination test is not a "Gold Standard"].
    Levy G
    Transfus Clin Biol; 2008 Nov; 15(5):318-21. PubMed ID: 18930684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unreliable patient identification warrants ABO typing at admission to check existing records before transfusion.
    Ferrera-Tourenc V; Lassale B; Chiaroni J; Dettori I
    Transfus Clin Biol; 2015 Jun; 22(2):66-70. PubMed ID: 25936944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
    Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
    Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diversity of bedside pretransfusion ABO compatibility devices in metropolitan France].
    Migeot V; Tellier S; Ingrand P
    Transfus Clin Biol; 2003 Feb; 10(1):26-36. PubMed ID: 12668185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a computer crossmatch in the absence of an immediate-spin antibody screen adequate for persons identified to be at increased risk of forming new blood group antibodies?
    Sandler SG; Abedalthagafi M; Langeberg A
    Transfusion; 2008 Oct; 48(10):2265-6. PubMed ID: 18928510
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology.
    ; Milkins C; Berryman J; Cantwell C; Elliott C; Haggas R; Jones J; Rowley M; Williams M; Win N
    Transfus Med; 2013 Feb; 23(1):3-35. PubMed ID: 23216974
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serious events: from statutory requirements to the implementation].
    Aullen JP; Lassale B; Verdot JJ
    Transfus Clin Biol; 2008 Nov; 15(5):217-22. PubMed ID: 18938098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemovigilance: concept, Europe and UK initiatives.
    McClelland B; Love E; Scott S; Williamson LM
    Vox Sang; 1998; 74 Suppl 2():431-9. PubMed ID: 9704478
    [No Abstract]   [Full Text] [Related]  

  • 19. The French haemovigilance system.
    Noel L; Debeir J; Cosson A
    Vox Sang; 1998; 74 Suppl 2():441-5. PubMed ID: 9704479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO blood group discrepancies among blood donors in Regional Blood Transfusion Centre GTB Hospital, Delhi, India.
    Sharma T; Garg N; Singh B
    Transfus Apher Sci; 2014 Feb; 50(1):75-80. PubMed ID: 24314713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.